Author:
Alshahrani Saad M.,Alshetaili Abdullah S.,Alalaiwe Ahmed,Alsulays Bader B.,Anwer Md. Khalid,Al-Shdefat Ramadan,Imam Faisal,Shakeel Faiyaz
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference53 articles.
1. Mendel DB, Laird AD, Xin X, Louie SG, Christensen JG, Li G, et al. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin Cancer Res. 2003;9:327–37.
2. Zheng X, Zhang Y, Zhang L, Xu W, Ma W, Sun R, et al. Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation. Biomed Pharmacother. 2016;83:212–20.
3. Kwon HJ, Kim Y, Sugihara Y, Baldetorp B, Welinder C, Watanabe K, et al. Drug compound characterization by mass spectrometry imaging in cancer tissue. Arch Pharm Res. 2015;38:1718–28.
4. Dong M, Phan AT, Yao JC. New strategies for advanced endocrine tumors in the era of targeted therapy. Clin Cancer Res. 2012;18:1830–6.
5. Sun J, Sun Q, Brown MF, Dudgeon C, Chandler J, Xu X, et al. The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA. PLoS One. 2012;7:E43158.
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献